| 000 | 01719 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517021534.0 | ||
| 264 | 0 | _c20160322 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1942-0870 | ||
| 024 | 7 |
_a10.1080/19420862.2015.1022693 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzzopardi, Nicolas | |
| 245 | 0 | 0 |
_aDose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. _h[electronic resource] |
| 260 |
_bmAbs _c2015 |
||
| 300 |
_a630-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTelangiectasia, Hereditary Hemorrhagic _xblood |
| 700 | 1 | _aDupuis-Girod, Sophie | |
| 700 | 1 | _aTernant, David | |
| 700 | 1 | _aFargeton, Anne-Emmanuelle | |
| 700 | 1 | _aGinon, Isabelle | |
| 700 | 1 | _aFaure, Frédéric | |
| 700 | 1 | _aDecullier, Evelyne | |
| 700 | 1 | _aRoux, Adeline | |
| 700 | 1 | _aCarette, Marie-France | |
| 700 | 1 | _aGilbert-Dussardier, Brigitte | |
| 700 | 1 | _aHatron, Pierre-Yves | |
| 700 | 1 | _aLacombe, Pascal | |
| 700 | 1 | _aLeguy-Seguin, Vanessa | |
| 700 | 1 | _aRivière, Sophie | |
| 700 | 1 | _aCorre, Romain | |
| 700 | 1 | _aBailly, Sabine | |
| 700 | 1 | _aPaintaud, Gilles | |
| 773 | 0 |
_tmAbs _gvol. 7 _gno. 3 _gp. 630-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/19420862.2015.1022693 _zAvailable from publisher's website |
| 999 |
_c24688771 _d24688771 |
||